Objectives-To assess the acute and chronic ophthalmological effects oftriethylamine exposure among foundry workers. Methods-Ocular effects on people currently, previously, and never exposed to triethylamine in a foundry cold box were studied at two points in time. The initial phase included an ocular examination with a slit lamp to assess corneal health, a visual acuity test, and a questionnaire to assess vision symptoms. The follow up included measurements of corneal thickness with an ultrasonic pachymeter and the vision symptoms questionnaire before and after the shift and at the beginning and end of the week. Personal air measurements for triethylamine were also obtained during the follow up. Results-The vision symptoms of blurriness, halos around lights, and blue hazy vision occurred more often in currently exposed workers than those previously or never exposed to triethylamine. Air concentrations of triethylamine ranged from < 0'33 mglm' to 20-3 mglm3. Among currently exposed workers, symptoms were more common among those with exposure to > 10 mg/m3 of triethylamine (odds ratio (OR) = 3'0, 95% confidence interval (95% CI) 0.35-25.6). No differences in corneal thickness were found in currently or previously exposed workers and those never exposed. No increase in corneal thickness was found after v before the shift.
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Conclusion-Despite low concentrations of triethylamine and no corneal oedema, workers exposed to triethylamine reported vision symptoms. Possible explanations for these symptoms without corneal oedema are that triethylamine affects ciliary muscle function or that the corneal oedema was transient and not present when corneal thickness measurements were taken. No chronic effects were found in previously exposed workers. Further research is needed to elucidate the mechanism for the reported vision symptoms, which occurred below the current United States eight hour time weighted standard of 100 mg/ml and the American Conference of Governmental Industrial Hygienists (ACGIH) recommended value at the time of our study of 40 mg/ml. We recommend that air concentrations be maintained to -0-001  -0-001  -0-001  2  3-72  ----+   -+0-002  +0 003  +0 003  3  2-64  -+  +   -0-019  +0-001  -0 009  4  9-83  +   --No data  No data  -0-006  + 0003  -0-002  5  7-19  -+  +  +  +  +   -0-002  +0-001  -0-001  6 14-54 --- to assess corneal health, a test of visual acuity, and a questionnaire to assess vision symptoms. The follow up eye examinations used a portable ultrasonic pachymeter to measure corneal thickness and a vision symptoms questionnaire to assess symptoms at the time of the pachymetry measurements. The second phase also included personal air sampling for triethylamine. The protocol was approved as part of a larger study protocol by Michigan State University's Committee on Research Involving Human Subjects.
SELECTION OF STUDY PARTICIPANTS
The currently exposed group was defined as cold box operators and their supervisors. To assess the possibility of chronic ophthalmological effects from triethylamine after exposure ended, one control group was composed of previously exposed people. A second control group was composed of people who had never worked as cold box operators. Controls were randomly selected from current employees who were not cold box operators. We attempted to select one control for each exposed subject.
To maximise the chance of finding a chronic effect, we identified all workers who had documentation from the medical department of a previous acute exposure to triethylamine during leaks; six workers were identified. One of the six was identified from the company's 1990 Occupational Safety and Health Administration injury and illness records; the other five were identified from a log book kept by the company physician from 1984 to 1985. Controls were matched to exposed subjects on age within three years, race, and sex, with nine exceptions. Two controls differed from the currently exposed group by more than three years of age; two differed by race; and five previously exposed workers differed by more than three years of age and by race.
OPHTHALMOLOGICAL EXAMINATIONS
The first eye examination clinic was held at the foundry medical department, with two ophthalmologists. The examination included a Snellen vision test for visual acuity, a slit lamp examination of the anterior segment of the eye, and a questionnaire to assess ocular symptoms without reference to time that included ever experiencing blurry vision, halo vision, blue vision, eye irritation, and a medical history of eye problems. The second eye examination clinic was also held at the foundry, in a room separated from but near the cold box production area. Measurements before and after the shift of corneal thickness of cold box operators were performed on a day at the beginning of the working week and on a day at the end of the working week. The previously and never exposed groups had one measurement of corneal thickness performed in the middle of the shift on one day during the course of the week. The corneal thickness was measured with a hand held ultrasonic pachymeter, the Pach Pen manufactured by Oculab (Glendale, CA). All measurements were taken in mm to one thousandth at the centre of the cornea.
One to two drops of the same anaesthetic were placed in each eye of both exposed and control subjects. conducted throughout the week of the follow up examinations. Samples were collected on charcoal tubes and analysed by gas chromatography. On one day parallel sampling was performed with silica gel collection tubes. Also, cold box operators and their supervisors were questioned at the end of their shift about any leaks that day or being able to smell triethylamine during their shift. ANALYSES x2, t tests, general linear models (GLM) procedure, and the Wilcoxon rank sum scores procedure were used to make comparisons of differences and changes in eye thickness within and between shifts and days for the currently exposed group and between the currently exposed and control groups.
Results
For the initial examination, 74 workers were invited and 66 actually participated: 20 currently exposed, 23 previously exposed, and 23 never exposed. Two workers could not attend for unrelated medical reasons and another six chose not to participate. At the follow up examination, 51 of the original 66 workers participated: 11 currently exposed, 23 previously exposed, and 17 never exposed. The exposure of five currently exposed workers from the initial examination changed to previously exposed in the follow up examination. Two workers in the previously exposed group during the follow up examination were only included in the initial analyses as they filled in as cold box operators on the day of the follow up examination.
The currently, previously, and never exposed groups were similar in mean age (38-6, 43.3, and 41-5 years), ethnic composition (% black: 55%, 61%, and 61%, P = 0 9054), and sex (% men: 100%, 87%, and 96%, P = 0-1846). Table 1 shows vision symptoms that have previously been reported to be associated with exposure to triethylamine. At the initial examination, the currently exposed group had significantly higher percentages of workers who reported blurry vision, halos, blue vision, and trouble with driving.
The follow up examination assessed the same vision symptoms actually on that day (table 1). For both days of the follow up examinations, the currently exposed group had significantly higher numbers of people with blurry vision (except after the shift on day 1), halos around lights, and blue vision. No workers experienced trouble with driving due to vision problems after the shift on the actual days of the follow up examinations.
As well as the vision symptoms shown in table 1, the three groups were assessed for pain, redness and burning of the eyes, and sensitivity to light; there were no significant differences between the groups. Only two workers in the study ever wore contact lenses; one had not worn them for a year and the other had not worn them for at least 18 hours before the first examination and had discontinued wearing them when the second examination was conducted. There was no difference among the three groups in the frequency of use of eye drops or ever having had an eye injury. No one in any of the three groups was taking eye medications or had a family history of eye disease. For specific types of eye injuries, the previously and never exposed groups had a significantly greater number of workers who had had a foreign object removed or a scratch of the eye.
A comparison of the mean measurements for visual acuity without correction, with correction, and pinhole showed no differences among the three exposure groups. Stromal opacities (scars) and guttata (corneal endothelial deposits) were found in members of each exposure group; no one had corneal oedema. There were no significant differences in either the right or left eyes between the currently, previously, or never exposed groups for either abnormal conjunctiva (right eye: 5%, 4%, and 4%, P = 0-9932; left eye: 5%, 4%, 0%, P = 0-5716) or corneas (right eye: 25%, 52%, 35%, P = 0-1737; left eye: 35%, 48%, 30%, P = 0 4540). Except for one previously exposed worker with shallow depth, the study participants had normal anterior chambers and lenses. Table 2 shows air monitoring results for triethylamine for each person in the currently exposed group, along with their reported symptoms, triethylamine leaks, or excessive exposures, and changes in corneal thickness. Triethylamine exposures measured during the two days ranged from <0'33 mg/M3 to 20-3 mg/m.3 Changes in corneal thickness by comparison of values before to after the shift both increased and decreased and were not necessarily in the same direction for both eyes. Increases in corneal thickness ranged from 0-001 mm to 0-011 mm; decreases ranged from 0-001 mm to 0-020 mm. No significant differences were found in the mean central corneal thickness for each exposure group by shift and day (table 3) . The mean central corneal thicknesses ranged from 0-511 mm to 0-525 mm. For the currently exposed group, three of the four mean before and after shift corneal thickness measurements in the right and left eyes showed decreases in corneal thickness by the end of the shift on both days. When changes in corneal thickness for both right and left eye were combined, both days showed a decrease in corneal thickness of 0-003 mm; the decrease on the first day but not the second day was significant (P = 0-0470 and P = 0-2271 respectively). Table 4 shows that all but two of the mean central corneal thickness measurements of the currently exposed group were decreased on the second day at the end of the working week compared with the first day at the beginning of the work week; two of the decreases were significant.
To determine if increases in corneal thickness were associated only with symptomatic workers, the exposure groups were stratified according to reports of vision symptoms. None of these differences were significant (table 5) . Table 6 shows that people exposed to > 10 mg/M3 of triethylamine were three times more likely to have one or more symptoms associated with triethylamine exposure than those with <10 mg/M3 exposure; this finding was not significant.
Comparisons of corneal thickness between workers with exposure to <10 mg/M3 and ) 10 mg/M3 were made (table 7) . Corneal thickness measurements decreased during a shift in both exposure categories. Between exposure categories, corneal thickness measurements were larger in people exposed to > 10 mg/M3 triethylamine. This difference was significant in the left eye for the measurements before the shift.
Discussion
Central corneal thickness under normal conditions has been reported by several researchers. Ranges reported are from 0 507 (0-028) to 0-565 (0 035) mm.910 We found corneal thicknesses from 0-470 to 0-567 mm among workers currently exposed to triethylamine, 0-460 to 0-583 mm among those previously exposed, and 0-456 to 0-620 mm among those never exposed (table 3) . These results are close to the reported normal range of central corneal thickness.
At the first eye examination, the two ophthalmologists, one a corneal specialist, found no corneal oedema with a slit lamp. The significant differences in reports of vision symptoms between the three groups were for the symptoms of blurry vision, halos around lights, blue vision, and trouble with driving (table 1) , all of which have been associated with exposure to triethylamine. [1] [2] [3] [4] [5] [6] [7] Other symptoms such as eye irritation, eye redness, sensitivity to light, and eye pain were similar among the three groups.
At the follow up eye examinations the exposed group again reported the symptoms of blurry vision, halos, and blue vision more often than the previously and never exposed groups (table 1). In the examinations after a shift the subjects were asked to report symptoms that had occurred during that shift. No differences in corneal thickness between the currently and previously or never exposed groups or differences between before and after the shift measurements suggested corneal oedema as the mechanism for these symptoms (tables 2, 3, and 4) .
Vision symptoms after exposure to tertiary amines have been associated with increases in corneal thickness that ranged from 0 03 to 0 10 mm. Stahlbom and colleagues reported slight oedema (approximately 0 03 mm increase) in two of four subjects exposed to as little as 10 mg/M3 of dimethylethylamine.6
Akesson and colleagues exposed two subjects to different concentrations and durations of triethylamine in an exposure chamber.' They found symptoms of hazy and halo vision after eight hours of exposure at concentrations as low as 18 mg/m3 of triethylamine, along with an increase in corneal thickness of 0-03 mm.
At an exposure of 10 mg/m3 of triethylamine for eight hours, the two subjects experienced no effects. Akesson and colleagues concluded that an exposure of 18 mg/m3 for eight hours can cause corneal oedema. The triethylamine exposures we measured ranged from <0 33 mg/m3 to 20-3 mg/m3. The changes in corneal thickness we measured ranged from a decrease of 0-020 mm to an increase of 0 011 mm within a shift. The maximum change in corneal thickness that we noted was less than the minimum change of corneal thickness associated with symptoms in the experimental settings reported by Akesson and Stahlbom.36 We compared mean corneal thickness of currently exposed workers with one or more eye symptoms to those with no symptoms. There were no significant changes over the shift that showed an increase in corneal thickness in either symptom level group. Workers with one or more symptoms had thicker corneas than the previously and never exposed groups. Differences in corneal thickness were as great as 0-032 mm, which is the minimum difference associated with symptoms in experimental settings. None of these differences were significant (table 5) .
We also examined whether the workers who had exposures to triethylamine ) 10 mg/m3, were more symptomatic and had increased corneal thickness. Although not significant, there was a threefold increase in eye symptoms among the workers exposed to 1O mg/iM3 of triethylamine (table 6) . We found, however, no increase in corneal thickness before and after the shift in either eye in the workers exposed to ) 10 mg/mi (table 7) .
There was a significant difference of 0-03 mm in the mean corneal thickness of the left eye on the measurements before the shift between people exposed to . 10 mg/M3 v those exposed to <10 mg/M3 (table 7) . After the shift the difference was similar (0-026 mm) but not significant. Although the differences in corneal thickness and symptoms between workers exposed to > 10 mg/M3 and <10 mg/M3 are consistent, one would also have expected to see a change from before to after the shift in the >10 mg/M3 group if an increase in corneal thickness is an explanation of the workers' symptoms.
One other researcher has reported symptoms at similar levels of exposure as our study group. Akesson et al examined 19 workers exposed to triethylamine in a polyurethane foam production plant.4 Central corneal thickness measured from 0 53 mm to 0-61 mm, and workers reported symptoms of foggy, blue, and halo vision, which were usually preceded by eye irritation. Exposures ranged from 4 to 28 mg/M3 in the areas where workers reported visual disturbances. Exposures for two hours were not associated with any vision disturbances. The researchers did not find any corneal oedema but measurements were not taken immediately after exposure. The authors hypothesised that the reason symptoms occurred at such low exposures was that there may have been peak exposures of high concentrations of triethylamine during the course of the shift. 4 In contrast, we performed our corneal thickness measurements immediately after the shift and found no changes in corneal thickness over the shift. Alternative explanations for our findings are that symptoms are related to another exposure, that the mechanism for triethylamine or another exposure causing symptoms is not through corneal oedema, that there is a small increase in corneal thickness over time that is not reflected in changes in an eight hour shift, or that corneal oedema is transient.
None of the other exposures in the cold box area have been previously associated with the vision symptoms of haziness, blue colour, and halos. Further, isolated exposure to triethylamine in experimental settings has caused these vision symptoms. Amines have been noted to have other effects on the eye, including mydriasis and cycloplegia.' Neither of these abnormalities were noted on physical examination although no measurements were performed to measure changes in pupil size or reaction. Finally, although there were differences in corneal thickness between currently exposed and previously or never exposed people, there was no difference between corneal measurements before the shift at the beginning of the week and measurements after the shift at the end of the week. No chronic corneal changes were noted after exposure to triethylamine. All the small differences in corneal thickness found are within the clinically normal range.
None of the alternative hypotheses adequately explain the presence of symptoms in the exposed workers or the increased symptoms in the group exposed to > Small numbers limited our ability to find significant differences, but even in the absence of a significant difference the direction of the findings, although supporting an association between symptoms and exposure, did not support an association between corneal thickness and exposure.
Conclusion
In summary, the air monitoring results showed exposures to triethylamine that ranged from <0 33 mg/M3 to 20-3 mg/M3. Despite these relatively low air concentrations and the absence of corneal oedema, workers reported vision symptoms associated with exposure to triethylamine. It is possible that the exposures were low enough that oedema did not occur, although corneal oedema has been reported with an exposure as low as 18 mg/M3 for eight hours in one study.3 Another possibility is that variability between people or unmeasured peak excursions caused transient changes in corneal thickness that were not present on measurements after the shift. Amines have been noted to cause mydriasis and cycloplegia and this effect on the ciliary muscle instead of corneal oedema warrants further study as this may be the mechanism for the symptoms found at these relatively low concentrations.' Further studies need to be performed to attempt to correlate objective signs of decrements in visual acuity with the reported vision symptoms. One relatively new test that may prove to be useful to this end is contrast sensitivity, which tests a person's ability to discriminate between levels of contrast. The current Occupational Safety and Health Administration standard for an eight hour exposure to triethylamine is 100 mg/M3. At the time of our study the ACGIH recommend a concentration of 40 mg/M3. Although we are unable to explain the mechanism, we found that vision symptoms occurred at concentrations lower than both the current Occupational Safety and Health Administration standard and the recommended ACGIH concentration at the time of our study. Although no chronic eye problems were found, the potential for an acute injury at work or while driving home because of difficulty in seeing indicates a need to minimise exposure to triethylamine below those standards currently considered acceptable. Given that 59% of the workers experienced symptoms at or below the recommended ACGIH concentration at the time of our study, our data would support the new lower recommended ACGIH concentration of 4d1 mg/M3. 
